CDKN2A and glioma: used Cre recombinase to knock in mutant PDGFRA combined with Ink4a/ARF -/- in OPCs of mice to cause development of brain tumors resembling anaplastic human gliomas, emphasizing the importance of PDGFRA as an early driver of malignant transformation of OPCs (44).